Selection of perforin expressing CD4+ adenovirus-specific T-cells with artificial antigen presenting cells

Clinical Immunology

Volumn 146, Issue 3, 2013, Pages 228-239

  Haveman, Lianne M ^a,c   Bierings, Marc ^a   Klein, Mark R ^a   Beekman, Jeffrey M ^a   de Jager, Wilco ^a   Kuis, Wietse ^a   Albani, Salvatore ^b   Prakken, Berent J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF ARIZONA   (United States)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Adenovirus specific T cells; Adoptive therapy; Artificial APCs

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANZYME B; HLA ANTIGEN CLASS 2; INTERLEUKIN 17; INTERLEUKIN 1BETA; LIPOSOME; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PERFORIN; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; ADENOVIRUS INFECTION; ALLOIMMUNITY; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL ISOLATION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE REACTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOVIRUS INFECTIONS, HUMAN; ADULT; ANTIGEN-PRESENTING CELLS; ANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; GRANZYMES; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE CULTURE TEST, MIXED; PEPTIDES; PERFORIN;

EID: 84873732402     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2013.01.002     Document Type: Article

References (44)

1. Howard D.S., Phillips G.L., Reece D.E., Munn R.K., Henslee-Downey J.J., Pittard M., Barker M., Pomeroy C. Adenovirus infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 1999, 29:1494-1501.
2. Hale G.A., Heslop H.E., Krance R.A., Brenner M.A., Jayawardene D., Srivastava D.K., Patrick C.C. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant. 1999, 23:277-282.
3. Chakrabarti S., Mautner V., Osman H., Collingham K.E., Fegan C.D., Klapper P.E., Moss P.A., Milligan D.W. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 2002, 100:1619-1627.
4. Myers G.D., Krance R.A., Weiss H., Kuehnle I., Demmler G., Heslop H.E., Bollard C.M. Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath). Bone Marrow Transplant. 2005, 36:1001-1008.
5. van Tol M.J., Kroes A.C., Schinkel J., Dinkelaar W., Claas E.C., Jol-van der Zijde C.M., Vossen J.M. Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery. Bone Marrow Transplant. 2005, 36:39-50.
6. + T-cell epitope. Hum. Gene Ther. 2002, 13:1167-1178.
7. Flomenberg P., Piaskowski V., Truitt R.L., Casper J.T. Characterization of human proliferative T cell responses to adenovirus. J. Infect. Dis. 1995, 171:1090-1096.
8. Onion D., Crompton L.J., Milligan D., Moss P.A., Lee S.P., Mautner V. The CD4+ T-cell response to adenovirus is focused against conserved residues within the hexon protein. J. Gen. Virol. 2007, 88:2417-2425.
9. Chatziandreou I., Gilmour K.C., McNicol A.M., Costabile M., Sinclair J., Cubitt D., Campbell J.D., Kinnon C., Qasim W., Gaspar H.B. Capture and generation of adenovirus specific T cells for adoptive therapy. Br. J. Haematol. 2006, 132:117-126.
10. Tang J., Olive M., Pulmanausahakul R., Schnell M., Flomenberg N., Eisenlohr L., Flomenberg P. Human CD8+ cytotoxic T cell responses to adenovirus capsid proteins. Virology 2006, 350:312-322.
11. Leen A.M., Sili U., Savoldo B., Jewell A.M., Piedra P.A., Brenner M.K., Rooney C.M. Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications. Blood 2004, 103:1011-1019.
12. Leen A.M., Christin A., Khalil M., Weiss H., Gee A.P., Brenner M.K., Heslop H.E., Rooney C.M., Bollard C.M. Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy. J. Virol. 2008, 82:546-554.
13. + adenovirus-specific T cells: implications for immunotherapy and gene therapy. J. Virol. 2003, 77:6562-6566.
14. Veltrop-Duits L.A., Heemskerk B., Sombroek C.C., van Vreeswijk T., Gubbels S., Toes R.E., Melief C.J., Franken K.L., Havenga M., van Tol M.J., Schilham M.W. Human CD4+ T cells stimulated by conserved adenovirus 5 hexon peptides recognize cells infected with different species of human adenovirus. Eur. J. Immunol. 2006, 36:2410-2423.
15. Feuchtinger T., Lücke J., Hamprecht K., Richard C., Handgretinger R., Schumm M., Greil J., Bock T., Niethammer D., Lang P. Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation. Br. J. Haematol. 2005, 128:503-509.
16. Myers G.D., Bollard C.M., Wu M.F., Weiss H., Rooney C.M., Heslop H.E., Leen A.M. Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2005, 36:1001-1008.
17. + T cells according to IFN-gamma secretion for adjuvant immunotherapy. Exp. Hematol. 2004, 32:282-289.
18. Hamel Y., Blake N., Gabrielsson S., Haigh T., Jooss K., Martinache C., Caillat-Zucman S., Rickinson A.B., Hacein-Bey S., Fischer A., Cavazzana-Calvo M. Adenovirally transduced dendritic cells induce bispecific cytotoxic T lymphocyte responses against adenovirus and cytomegalovirus pp 65 or against adenovirus and Epstein-Barr virus EBNA3C protein: a novel approach for immunotherapy. Hum. Gene Ther. 2002, 13:855-866.
19. Smith C.A., Woodruff L.S., Kitchingman G.R., Rooney C.M. Adenovirus-pulsed dendritic cells stimulate human adenovirus-specific T-cell responses in vitro. J. Virol. 1996, 70:6733-6740.
20. Comoli P., Schilham M.W., Basso S., van Vreeswijk T., Bernardo M.E., Maccario R., van Tol M.J., Locatelli F., Veltrop-Duits L.A. T-cell lines specific for peptides of adenovirus hexon protein and devoid of alloreactivity against recipient cells can be obtained from HLA-haploidentical Donors. J. Immunother. 2008, 31:529-536.
21. Mallet-Designe V.I., Stratmann T., Homann D., Carbone F., Oldstone M.B., Teyton L. Detection of low-avidity CD4+ T cells using recombinant artificial APC: following the antiovalbumin immune response. J. Immunol. 2003, 170:123-131.
22. Prakken B., Wauben M., Genini D., Samodal R., Barnett J., Mendivil A., Leoni L., Albani S. Artificial antigen-presenting cells as a tool to exploit the immune 'synapse'. Nat. Med. 2000, 6:1406-1410.
23. de Kleer I., Vastert B., Klein M., Teklenburg G., Arkesteijn G., Yung G.P., Albani S., Kuis W., Wulffraat N., Prakken B. Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. Blood 2006, 107:1696-1702.
24. Haveman L.M., Bierings M., Legger E., Klein M.R., de Jager W., Otten H.G., Albani S., Kuis W., Sette A., Prakken B.J. Novel pan-DR-binding T cell epitopes of adenovirus induce pro-inflammatory cytokines and chemokines in healthy donors. Int. Immunol. 2006, 18:1521-1529.
25. Rammensee H., Bachmann J., Emmerich N.P., Bachor O.A., Stevanović S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999, 50:213-219.
26. Schagen F.H., Moor A.C., Cheong S.C., Cramer S.J., van Ormondt H., van der Eb A.J., Dubbelman T.M., Hoeben R.C. Photodynamic treatment of adenoviral vectors with visible light: an easy and convenient method for viral inactivation. Gene Ther. 1999, 6:873-881.
27. de Jager W., te Velthuis H., Prakken B.J., Kuis W., Rijkers G.T. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin. Diagn. Lab. Immunol. 2003, 10:133-139.
28. Jedema I., van der Werff N.M., Barge R.M., Willemze R., Falkenburg J.H. New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population. Blood 2004, 103:2677-2682.
29. Koffeman E., Keogh E., Klein M.R., Prakken B.J., Albani S. Identification and manipulation of antigen specific T-cells with artificial antigen presenting cells. Methods Mol. Med. 2007, 136:69-86.
30. de Kleer I.M., Wedderburn L.R., Taams L.S., Patel A., Varsani H. CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J. Immunol. 2004, 15(172):6435-1643.
31. Martinvalet D., Thiery J., Chowdhury D. Granzymes and cell death. Methods Enzymol. 2008, 442:213-230.
32. Van de Berg P.J., van Leeuwen E.M., Ten Berge I.J., van Lier R. Cytotoxic human CD4(+) T cells. Curr. Opin. Immunol. 2008, 20:339-343.
33. Mistchenko A.S., Koch E.R.R., Kajon A.E., Tibaldi F., Maffey A.F., Diez R.A. Lymphocyte subsets and cytokines in adenoviral infection in children. Acta Paediatr. 1998, 87:933-939.
34. Ljungman P. Treatment of adenovirus infections in the immunocompromised host. Eur. J. Clin. Microbiol. Infect. Dis. 2004, 23:583-538.
35. Heemskerk B., Lankester A.C., van Vreeswijk T., Beersma M.F., Claas E.C., Veltrop-Duits L.A., Kroes A.C., Vossen J.M., Schilham M.W., van Tol M.J. Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients. J. Infect. Dis. 2005, 191:520-530.
36. Kampmann B., Cubitt D., Walls T., Naik P., Depala M., Samarasinghe S., Robson D., Hassan A., Rao K., Gaspar H., Davies G., Jones A., Cale C., Gilmour K., Real M., Foo M., Bennett-Rees N., Hewitt A., Amrolia P., Veys P. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br. J. Haematol. 2005, 130:595-603.
37. Feuchtinger T., Matthes-Martin S., Richard C., Lion T., Fuhrer M., Hamprecht K., Handgretinger R., Peters C., Schuster F.R., Beck R., Schumm M., Lotfi R., Jahn G., Lang P. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br. J. Haematol. 2006, 134:64-76.
38. Appay V., Zaunders J.J., Papagno L., Sutton J., Jaramillo A., Waters A., Easterbrook P., Grey P., Smith D., McMichael A.J., Cooper D.A., Rowland-Jones S.L., Kelleher A.D. Characterization of CD4(+) CTLs ex vivo. J. Immunol. 2002, 168:5954-5958.
39. Williams N.S., Engelhard V.H. Identification of a population of CD4+ CTL that utilizes a perforin - rather than a Fas ligand-dependent cytotoxic mechanism. J. Immunol. 1996, 156:153-159.
40. Heemskerk B., van Vreeswijk T., Veltrop-Duits L.A., Sombroek C.C., Franken K., et al. Adenovirus-specific CD4+ T cell clones recognizing endogenous antigen inhibit viral replication in vitro through cognate interaction. J. Immunol. 2006, 15(177):8851-8859.
41. Einsele H., Roosnek E., Rufer N., Sinzger C., Riegler S., Löffler J., Grigoleit U., Moris A., Rammensee H.G., Kanz L., Kleihauer A., Frank F., Jahn G., Hebart H. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood 2002, 99:3916-3922.
42. Peggs K.S., Verfuerth S., Pizzey A., Khan N., Guiver M., Moss P.A., Mackinnon S. Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. Lancet 2003, 362:1375-1377.
43. Papanicolaou G.A., Latouche J.B., Tan C., Dupont J., Stiles J., Pamer E.G., Sadelain M. Rapid expansion of cytomegalovirus-specific cytotoxic T lymphocytes by artificial antigen-presenting cells expressing a single HLA allele. Blood 2003, 102:2498-2505.
44. Rauser G., Einsele H., Sinzger C., Wernet D., Kuntz G., Assenmacher M., Campbell J.D., Topp M.S. Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants. Blood 2004, 103:3565-3572.